These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 10852437

  • 1. Hashimoto's thyroiditis with heterogeneous antithyrotropin receptor antibodies: unique epitopes may contribute to the regulation of thyroid function by the antibodies.
    Akamizu T, Kohn LD, Hiratani H, Saijo M, Tahara K, Nakao K.
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2116-21. PubMed ID: 10852437
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Characterization of thyroid-stimulating blocking antibodies that appeared during transient hypothyroidism after radioactive iodine therapy.
    Kung AW, Lau KS, Kohn LD.
    Thyroid; 2000 Oct; 10(10):909-17. PubMed ID: 11081257
    [Abstract] [Full Text] [Related]

  • 4. Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor.
    Morgenthaler NG, Pampel I, Aust G, Seissler J, Scherbaum WA.
    Horm Metab Res; 1998 Mar; 30(3):162-8. PubMed ID: 9566861
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
    Vitti P, Chiovato L, Fiore E, Mammoli C, Rocchi R, Pinchera A.
    Acta Med Austriaca; 1996 Mar; 23(1-2):52-6. PubMed ID: 8767515
    [Abstract] [Full Text] [Related]

  • 7. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
    Kosugi S, Ban T, Akamizu T, Kohn LD.
    Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
    [Abstract] [Full Text] [Related]

  • 8. Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor.
    Tahara K, Ishikawa N, Yamamoto K, Hirai A, Ito K, Tamura Y, Yoshida S, Saito Y, Kohn LD.
    Thyroid; 1997 Dec; 7(6):867-77. PubMed ID: 9459630
    [Abstract] [Full Text] [Related]

  • 9. Prevalence and clinical relevance of thyroid stimulating hormone receptor-blocking antibodies in autoimmune thyroid disease.
    Diana T, Krause J, Olivo PD, König J, Kanitz M, Decallonne B, Kahaly GJ.
    Clin Exp Immunol; 2017 Sep; 189(3):304-309. PubMed ID: 28439882
    [Abstract] [Full Text] [Related]

  • 10. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K, Yamazaki K, Yamada E, Kanaji Y, Miura M, Obara T.
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [Abstract] [Full Text] [Related]

  • 11. Thyrotropin receptor autoantibodies (TSHRAbs): epitopes, origins and clinical significance.
    Kohn LD, Harii N.
    Autoimmunity; 2003 Oct; 36(6-7):331-7. PubMed ID: 14669940
    [Abstract] [Full Text] [Related]

  • 12. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
    Morgenthaler NG, Ho SC, Minich WB.
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
    [Abstract] [Full Text] [Related]

  • 13. Evidence for thyrotropin (TSH)-blocking activity in goitrous Hashimoto's thyroiditis with assays measuring inhibition of TSH receptor binding and TSH-stimulated thyroid adenosine 3',5'-monophosphate responses/cell growth by immunoglobulins.
    Takasu N, Yamada T, Katakura M, Yamauchi K, Shimizu Y, Ishizuki Y.
    J Clin Endocrinol Metab; 1987 Feb; 64(2):239-45. PubMed ID: 2878935
    [Abstract] [Full Text] [Related]

  • 14. [Analysis of epitopes for TSH receptor autoantibodies using TSH receptor/LH-CG receptor chimeras].
    Tahara K, Yamamoto K, Tamura Y, Yoshida S.
    Nihon Rinsho; 1994 Apr; 52(4):1031-6. PubMed ID: 7515118
    [Abstract] [Full Text] [Related]

  • 15. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
    Akamizu T, Moriyama K, Miura M, Saijo M, Matsuda F, Nakao K.
    Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
    [Abstract] [Full Text] [Related]

  • 16. A TSHr-LH/CGr chimera that measures functional TSAb in Graves' disease.
    Giuliani C, Cerrone D, Harii N, Thornton M, Kohn LD, Dagia NM, Fiore E, Bucci I, Chamblin T, Vitti P, Monaco F, Napolitano G.
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1106-15. PubMed ID: 22496495
    [Abstract] [Full Text] [Related]

  • 17. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
    Chen W, Man N, Li YS, Shan ZY, Teng WP.
    Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
    [Abstract] [Full Text] [Related]

  • 18. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
    Kamijo K, Murayama H, Uzu T, Togashi K, Olivo PD, Kahaly GJ.
    Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
    [Abstract] [Full Text] [Related]

  • 19. Epitope heterogeneity of thyrotropin receptor-blocking antibodies in Graves' patients as detected with wild-type versus chimeric thyrotropin receptors.
    Grasso YZ, Kim MR, Faiman C, Kohn LD, Tahara K, Gupta MK.
    Thyroid; 1999 Jun; 9(6):531-7. PubMed ID: 10411114
    [Abstract] [Full Text] [Related]

  • 20. Epitopes for thyroid-stimulating antibodies in Graves' sera: a possible link of heterogeneity to differences in response to antithyroid drug treatment.
    Kim WB, Cho BY, Park HY, Lee HK, Kohn LD, Tahara K, Koh CS.
    J Clin Endocrinol Metab; 1996 May; 81(5):1758-67. PubMed ID: 8626830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.